Distinction of partially purified human natural killer cytotoxic factor from recombinant human tumor necrosis factor and recombinant human lymphotoxinBIALAS, T; KOLITZ, J; LEVI, E et al.Cancer research (Baltimore). 1988, Vol 48, Num 4, pp 891-898, issn 0008-5472Article

CD8 independence and specificity of cytotoxic T lymphocytes restricted by HLA-Aw68.1CERUNDOLO, V; TSE, A. G. D; SALTER, R. D et al.Proceedings of the Royal society of London. Series B. Biological sciences. 1991, Vol 244, Num 1310, pp 169-177, issn 0080-4649Article

Mucosal damage: A major risk factor for severe complications after cytotoxic therapyPETERSON, Douglas E; CARIELLO, Anna.Seminars in oncology. 2004, Vol 31, Num 3, pp 35-44, issn 0093-7754, 10 p., SUP8Conference Paper

Isolation and characterization of cytotoxic compounds from cornKUGA, H; EJIMA, A; MITUI, I et al.Bioscience, biotechnology, and biochemistry. 1993, Vol 57, Num 6, pp 1020-1021, issn 0916-8451Article

Production and partial characterization of a Vibrio fluvialis cytotoxinWALL, V. W; KREGER, A. S; RICHARDSON, S. H et al.Infection and immunity. 1984, Vol 46, Num 3, pp 773-777, issn 0019-9567Article

Electron microscope study on a transmissible cytotoxic factor isolated from cerebrospinal fluid of neurological patients: analysis of its structure and of its effects on various types of cell culturesGUERRA, D; RONCHETTI, I. I; BERETTI, F et al.Journal of clinical pathology. 2012, Vol 65, Num 1, pp 20-28, issn 0021-9746, 9 p.Article

Properties of cytotoxic peptide-formed ion channelsKOURIE, J. I; SHORTHOUSE, A. A.American journal of physiology. Cell physiology. 2000, Vol 47, Num 6, pp C1063-C1087, issn 0363-6143Article

Difference in cytotoxicity of (22R)-cholest-5-ene-3β,7α,22-triol and (22R)-cholest-5-ene-3β,7β,22-triol is not explained by different patterns of metabolitesBOBERG, K. M; SMITH-KIELLAND, I; STABURSVIK, A et al.Journal of steroid biochemistry. 1989, Vol 33, Num 6, pp 1087-1089, issn 0022-4731, 3 p.Article

Propiedades tóxicas de los Escherichia coli enteroinvasivos = Toxic properties of enteroinvasive Escherichia coli strainsBLANCO, M; GLANCO, J. E; BLANCO, J et al.Microbiologia (Madrid). 1993, Vol 9, Num 2, pp 149-152, issn 0213-4101Article

Kinetics of the hydrolysis of bisphenol F diglycidyl ether in water-based food simulants. Comparison with bisphenol A diglycidyl etherPASEIRO LOSADA, P; SIMAL LOZANO, J; PAZ ABUIN, S et al.Journal of agricultural and food chemistry (Print). 1992, Vol 40, Num 5, pp 868-872, issn 0021-8561Article

Multistage model of natural killer cell-mediated cytotoxicity involving NKCF as soluble cytotoxic mediatorsBONAVIDA, B; WRIGHT, S. C.Advances in cancer research. 1987, Vol 49, pp 169-187, issn 0065-230XArticle

Hydrogen peroxide : a potent cytotoxic agent effective in causing cellular damage and used in the possible treatment for certain tumoursSYMONS, M. C. R; RUSAKIEWICZ, S; REES, R. C et al.Medical hypotheses. 2001, Vol 57, Num 1, pp 56-58, issn 0306-9877Article

Cytotoxic treatment and alterations in kidney functionDONCKERWOLCKE, R. A; COPPES, M. J.Medical and pediatric oncology. 1998, Vol 30, Num 3, pp 178-179, issn 0098-1532Article

Tumor cytotoxic activity of HGF-SFHIGASHIO, K; SHIMA, N.Experientia. Supplementum. 1993, Num 65, pp 351-368, issn 0071-335XArticle

Production of enterotoxin, verotoxin, hemolysin and cytotoxic necrotizing factor by Escherichia coli of intestinal and extraintestinal originHOŠTACKÁ, A.Folia microbiologica. 1994, Vol 39, Num 1, pp 79-82, issn 0015-5632Article

A study of perforin appearing in human lymphokine-activated killer (LAK) cells derived from spleen and peripheral blood mononuclear cellsKATAOKA, K.Nippon Geka Gakkai Zasshi. 1992, Vol 93, Num 4, pp 352-362, issn 0301-4894Article

Bone marrow regeneration under cytotoxic drug regimens : behaviour ranging from homeostasis to unpredictability in a model for hemopoietic differentiationMEHR, R; AGUR, Z.Biosystems. 1992, Vol 26, Num 4, pp 231-237, issn 0303-2647Article

Laulimalides: new potent cytotoxic macrolides from a marine sponge and a nudibranch predatorCORLEY, D. G; HERB, R; MOORE, R. E et al.Journal of organic chemistry. 1988, Vol 53, Num 15, pp 3644-3646, issn 0022-3263Article

Proposal for classification of leukocyte-associated cytolytic molecules: Denver, Colorado, September 28, 1986KOREN, H; GOLDFORB, R; ZIEGLER-HEITBROCK, H. W. L et al.Journal of leukocyte biology. 1987, Vol 41, Num 5, pp 447-449, issn 0741-5400Article

Role of monocyte cytotoxic factor in cytolysis of actinomycin D-treated WEHI 164 cells mediated by freshly isolated human adherent mononuclear blood cellsAUSTGULEN, R; ESPEVIK, T; HAMMERSTRØM, J et al.Cancer research (Baltimore). 1986, Vol 46, Num 9, pp 4566-4570, issn 0008-5472Article

A killing defect of natural killer cells with the absence of natural killer cytotoxic factors in a child with Hodgkin's diseaseKOMIYAMA, A; KAWAI, H; YAMADA, S et al.Blood. 1987, Vol 69, Num 6, pp 1686-1690, issn 0006-4971Article

In vitro tumor cell cytolysis mediated by peptide defensins of human and rabbit granulocytesLICHTENSTEIN, A; GANZ, T; SELSTED, M. E et al.Blood. 1986, Vol 68, Num 6, pp 1407-1410, issn 0006-4971Conference Paper

Production of a cytotoxin from phorbol myristate acetate-treated human promyelocytesGIFFORD, G. E; FLICK, D. A; ABDALLAH, N. A et al.Journal of the National Cancer Institute. 1984, Vol 73, Num 1, pp 69-73, issn 0027-8874Article

Cytotoxic factor-autoantibodies : possible role in the pathogenesis of dengue haemorrhagic feverCHATURVEDI, U. C; ELBISHBISHI, E. A; AGARWAL, R et al.FEMS immunology and medical microbiology. 2001, Vol 30, Num 3, pp 181-186, issn 0928-8244Article

New agents for prostate cancerREESE, David M.Hematology/oncology clinics of North America. 2001, Vol 15, Num 3, issn 0889-8588, vii, 547-557 [12 p.]Article